Pages that link to "Q57043105"
Jump to navigation
Jump to search
The following pages link to Reversible decreases in N-acetylaspartate after acute brain injury (Q57043105):
Displaying 50 items.
- Is ischemia involved in the pathogenesis of murine cerebral malaria? (Q28350900) (← links)
- Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder (Q28366808) (← links)
- Magnetic resonance markers of ischaemia: their correlation with vasodilatory reserve in patients with carotid artery stenosis and occlusion (Q28367115) (← links)
- Axonal Transection in the Lesions of Multiple Sclerosis (Q29615585) (← links)
- Functional imaging and related techniques: an introduction for rehabilitation researchers (Q30472754) (← links)
- Single prolonged stress decreases glutamate, glutamine, and creatine concentrations in the rat medial prefrontal cortex (Q30474565) (← links)
- Magnetic resonance spectroscopic determination of a neuronal and axonal marker in white matter predicts reversibility of deficits in secondary normal pressure hydrocephalus (Q30495447) (← links)
- Neurochemical brain imaging investigations of schizophrenia (Q30581142) (← links)
- Assessment of posterior fossa damage in MS using MRI. (Q30585732) (← links)
- Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part I. (Q30611958) (← links)
- Linking structural, metabolic and functional changes in multiple sclerosis. (Q30654880) (← links)
- Magnetic resonance imaging and magnetic resonance spectroscopy in dementias (Q30660816) (← links)
- Application of magnetic resonance to animal models of cerebral ischemia. (Q30667083) (← links)
- Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage (Q30679381) (← links)
- A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra (Q30698264) (← links)
- Spectroscopic data following stroke reveal tissue abnormality beyond the region of T2-weighted hyperintensity. (Q30700152) (← links)
- Proton magnetic resonance spectroscopic imaging suggests progressive neuronal damage in human temporal lobe epilepsy. (Q30707515) (← links)
- Temporal lobectomy for epilepsy: recovery of the contralateral hippocampus measured by (1)H MRS. (Q30716820) (← links)
- Various MRS application tools for Alzheimer disease and mild cognitive impairment (Q30803093) (← links)
- The use of quantitative magnetic-resonance-based techniques to monitor the evolution of multiple sclerosis. (Q30810168) (← links)
- Occipital proton magnetic resonance spectroscopy (1H-MRS) reveals normal metabolite concentrations in retinal visual field defects (Q30829984) (← links)
- Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging (Q30835804) (← links)
- Brain proton magnetic resonance spectroscopy of alcohol use disorders (Q30859378) (← links)
- Neuroimaging in amyotrophic lateral sclerosis (Q30891437) (← links)
- MRI monitoring of pathological changes in the spinal cord in patients with multiple sclerosis (Q30906157) (← links)
- (1)H MR spectroscopy. Methods and applications in diagnosis and assessment of surgical and conservative treatment strategies in epilepsies (Q30930202) (← links)
- 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia. (Q30945792) (← links)
- ALS surrogate markers. MRS. (Q30974180) (← links)
- Neuroimaging in leukodystrophies (Q30978716) (← links)
- The aging hippocampus: navigating between rat and human experiments (Q30992138) (← links)
- Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research (Q30995022) (← links)
- Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis (Q30996805) (← links)
- Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis (Q31001850) (← links)
- N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease (Q31046921) (← links)
- [Magnetic resonance spectroscopy for inflammatory brain diseases]. (Q31156617) (← links)
- Proton magnetic resonance spectroscopy in alcohol use disorders: a potential new endophenotype? (Q31158547) (← links)
- Neuroimaging insights into the pathophysiology of sleep disorders (Q31158979) (← links)
- Biological markers in the diagnosis and treatment of ALS. (Q31389611) (← links)
- Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder (Q32079413) (← links)
- Proton magnetic resonance spectroscopy in brain white matter disorders (Q32101259) (← links)
- Magnetic resonance spectroscopyin vivo: applications in neurological disorders (Q32101276) (← links)
- In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders (Q32115381) (← links)
- Time course of postoperative recovery of N-acetyl-aspartate in temporal lobe epilepsy (Q32153970) (← links)
- Reanalysis of multislice (1)H MRSI in amyotrophic lateral sclerosis (Q32163064) (← links)
- Correlation of the apparent diffusion coefficient and the creatine level in early ischemic stroke: a comparison of different patterns by magnetic resonance (Q32163667) (← links)
- Assessing and predicting recovery from a coma following traumatic brain injury: contribution of neuroradiological data (Q33186613) (← links)
- N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology (Q33271816) (← links)
- Dicholine salt of succinic acid, a neuronal insulin sensitizer, ameliorates cognitive deficits in rodent models of normal aging, chronic cerebral hypoperfusion, and beta-amyloid peptide-(25-35)-induced amnesia (Q33316237) (← links)
- Serial proton MR spectroscopy and diffusion tensor imaging in infantile Balo's concentric sclerosis. (Q33380240) (← links)
- Proton magnetic resonance spectroscopy in multiple sclerosis (Q33390863) (← links)